{
    "title": "Medicare offers details on reimbursement for new Alzheimer's drugs",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12224597/Medicare-offers-details-reimbursement-new-Alzheimers-drugs.html",
    "date": "2023-06-22",
    "keywords": [
        "drug",
        "cms",
        "brain",
        "registry",
        "leqembi",
        "patient",
        "plan",
        "approval",
        "information",
        "amyloid",
        "trial",
        "health",
        "thursday",
        "reimbursement",
        "data",
        "medicare",
        "fact",
        "sheet",
        "disease",
        "treatment",
        "agency",
        "side",
        "swelling",
        "latestage",
        "condition",
        "co",
        "ltd",
        "biogen",
        "july",
        "government",
        "part",
        "collection",
        "effort",
        "medicaid",
        "website",
        "fda",
        "milestone",
        "course",
        "provider",
        "diagnosis",
        "blood",
        "risk",
        "cognitive",
        "fluid",
        "target",
        "backing",
        "panel",
        "food",
        "administration",
        "month",
        "companys",
        "study",
        "november",
        "decline",
        "bleeding",
        "evidence",
        "basis",
        "beta",
        "donanemab",
        "concern",
        "requirement",
        "access",
        "price",
        "year",
        "need",
        "coverage",
        "impairment",
        "dementia",
        "physician",
        "one",
        "reporting",
        "julie",
        "daniel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}